Literature DB >> 17526061

Chemical introduction of reactive thiols into a viral nanoscaffold: a method that avoids virus aggregation.

Nicole F Steinmetz1, David J Evans, George P Lomonossoff.   

Abstract

The use of viral nanoparticles (VNPs) as building blocks for material fabrication has received particular attention in recent years. In earlier studies we showed the applicability of native gel electrophoresis in an agarose matrix as a useful method for the characterization of chemically modified VNPs. Here, we extend these studies and analyze the observed band pattern of intact Cowpea mosaic virus (CPMV) VNPs in agarose gels and show the applicability of native agarose gels for monitoring interparticle linkage of thiol-containing CPMV mutant particles. In addition, we report a protocol that allows the introduction of acetate-protected thiols to CPMV by means of a chemical reaction (rather than genetic modification). The advantage of this approach is that, by incorporating protected thiol groups, the formation of disulfide bonds leading to interparticle linkage is prevented. The resulting thiol-modified CPMV-SH(n) particles are stable, and following deprotection, the introduced thiols are reactive and can be labeled with thiol-selective reagents. They therefore provide a useful additional building block in the CPMV toolbox.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526061     DOI: 10.1002/cbic.200700126

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  20 in total

1.  A potential nanobiotechnology platform based on infectious bursal disease subviral particles.

Authors:  Omid Taghavian; Manoj K Mandal; Nicole F Steinmetz; Stefan Rasche; Holger Spiegel; Rainer Fischer; Stefan Schillberg
Journal:  RSC Adv       Date:  2012-01-09       Impact factor: 3.361

2.  Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells.

Authors:  Rick K Huang; Nicole F Steinmetz; Chi-Yu Fu; Marianne Manchester; John E Johnson
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

3.  Freeze-Drying To Produce Efficacious CPMV Virus-like Particles.

Authors:  Yi Zheng; Parker W Lee; Chao Wang; Linda D Thomas; Phoebe L Stewart; Nicole F Steinmetz; Jonathan K Pokorski
Journal:  Nano Lett       Date:  2019-02-25       Impact factor: 11.189

4.  A Simple RNA-DNA Scaffold Templates the Assembly of Monofunctional Virus-Like Particles.

Authors:  Rees F Garmann; Richard Sportsman; Christian Beren; Vinothan N Manoharan; Charles M Knobler; William M Gelbart
Journal:  J Am Chem Soc       Date:  2015-06-10       Impact factor: 15.419

5.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

6.  Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.

Authors:  Chao Wang; Veronique Beiss; Nicole F Steinmetz
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  Buckyballs meet viral nanoparticles: candidates for biomedicine.

Authors:  Nicole F Steinmetz; Vu Hong; Erik D Spoerke; Ping Lu; Kurt Breitenkamp; M G Finn; Marianne Manchester
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

8.  PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo.

Authors:  Nicole F Steinmetz; Marianne Manchester
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

9.  Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments.

Authors:  Arpita Agrawal; Marianne Manchester
Journal:  Biomacromolecules       Date:  2012-09-20       Impact factor: 6.988

10.  The aspect ratio of nanoparticle assemblies and the spatial arrangement of ligands can be optimized to enhance the targeting of cancer cells.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Adv Healthc Mater       Date:  2014-04-14       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.